Blood loss during and after caesarean section
Conditions
Interventions
intravenous tranexamic acid
placebo
Sponsors
JEMIRIGBE OMAWUMI DARLINGTON
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Age between 20 to 40 years. Parity- 1 - 4 Gestational age of 37-40 weeks. Singleton live fetus with reassuring fetal heart rate. Elective repeat CS.
Exclusion criteria
Exclusion criteria: Refusal of the patient to give consent. Known allergy to intravenous tranexamic acid. Multiple pregnancies. Antepartum haemorrhage. Co-existing uterine fibroids. Macrosomic baby- birth weight =4kg. Intrauterine fetal death. Preeclampsia. Others are history of thromboembolic disease, medical conditions such as major liver, heart, kidney, brain and bleeding disorders, anticoagulant therapy, patients requiring blood transfusion due to anaemia and polyhydramnios. The medical conditions will be excluded from thorough history and examination of the patient and those with a positive history and examination findings suggestive of these medical conditions will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of blood loss during and after caesarean section. | — |
Secondary
| Measure | Time frame |
|---|---|
| Additional uterotonic drugs.;2. Blood transfusion. ;3. Surgical interventions.;Maternal and fetal side effects. | — |
Countries
Nigeria
Contacts
Public ContactOmawumi Jemirigbe
Senior Registrar
Outcome results
None listed